Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Victoria Ung"'
Autor:
Candace L. Beilman, Nguyen Xuan Thanh, Victoria Ung, Christopher Ma, Karen Wong, Karen I. Kroeker, Thomas Lee, Haili Wang, Arto Ohinmaa, Phil Jacobs, Brendan P. Halloran, Richard N. Fedorak
Publikováno v:
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapie
Externí odkaz:
https://doaj.org/article/3eca1e9914c54b52961f955879dd72ca
Autor:
Christopher Ma, Thomas Lee, Brendan P. Halloran, Karen I. Kroeker, Karen Wong, Victoria Ung, Candace L. Beilman, Arto Ohinmaa, Richard N. Fedorak, Haili Wang, P. Jacobs, Nguyen Xuan Thanh
Publikováno v:
Canadian Journal of Gastroenterology & Hepatology
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Canadian Journal of Gastroenterology and Hepatology, Vol 2016 (2016)
Background. Adalimumab is effective for the maintenance of remission in patients with moderate-to-severe ulcerative colitis (UC). Currently, biologic therapies are used in cases where patients fail conventional medical therapies. If biologic therapie
Autor:
Yvonne Doerffel, Hans Verstraelen, Victoria Ung, Beate C. Sydora, Richard N. Fedorak, Alexander Swidsinski, Vera Loening-Baucke
Publikováno v:
Inflammatory Bowel Diseases. 15:359-364
Background: Detergents and emulsifiers added to food may destroy the mucus barrier, which normally isolates bacteria from the intestinal wall, and lead to chronic bowel inflammation in susceptible persons. We investigated the influence of 2% carboxym
Autor:
Richard N. Fedorak, Candace L. Beilman, Arto Ohinmaa, Haili Wang, Karen I. Kroeker, Karen Wong, Thanh Nguyen, P. Jacobs, Brendan P. Halloran, Christopher Ma, Victoria Ung, Thomas Lee
Publikováno v:
Gastroenterology. 150:S631-S632
Real-life treatment paradigms show infliximab is cost-effective for management of ulcerative colitis
Autor:
Thomas Lee, Victoria Ung, Philip Jacobs, Karen Wong, Richard N. Fedorak, Haili Wang, Arto Ohinmaa, Karen I. Kroeker, Nguyen Xuan Thanh
Publikováno v:
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association. 12(11)
Background & Aims Infliximab is effective for induction and maintenance of response in patients with moderate to moderately severe ulcerative colitis. Previous cost analyses of infliximab treatment for ulcerative colitis used models of colectomy vs i
Autor:
Richard N. Fedorak, Haili Wang, Victoria Ung, Philip Jacobs, Karen I. Kroeker, Arto Ohinmaa, Thanh Nguyen, Thomas W. Lee, Karen Wong
Publikováno v:
Gastroenterology. 140:S-201